Atlanta, GA — September 2, 2026 — Andson Biotech is excited to announce its participation in the CASSS Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (CASSS MS 2026), taking place September 15-18, 2026, in Rockville, Maryland. During the meeting, Andson scientists will present new research demonstrating how automated online buffer exchange and microfluidic sample preparation technologies are enabling faster, more streamlined mass spectrometry workflows for biotherapeutic development and process monitoring.
As the biotechnology industry continues to pursue increasingly complex therapeutic modalities, there is growing demand for analytical solutions that reduce sample preparation burden while delivering rapid, high-quality insights. Andson Biotech’s automated online buffer exchange technology is helping researchers simplify workflows, improve reproducibility, and accelerate the adoption of native mass spectrometry and direct analysis approaches across biopharmaceutical applications.
Featured Scientific Presentations
Direct Secretome Profiling from Cell Culture Media Enabled by Microfluidic Online Buffer Exchange for In-Process Monitoring of Advanced Biotherapeutics
Presenter: Suraj Dhungana, PhD
Automated Online Buffer Exchange for Native Mass Spectrometry Protein-Ligand Screening Workflows
Presenter: Suraj Dhungana, PhD
Native Mass Spectrometry of Biotherapeutics via Automated Online Buffer Exchange: From Proteins to Viral Vectors
Presenter: Mason Chilmonczyk, PhD
Native mass spectrometry continues to gain momentum as a powerful tool for characterizing biomolecular interactions, biotherapeutics, and advanced therapeutic modalities. Furthermore, advances in new mass spectrometry instrumentation, fragmentation modes, and accessibility to large mass range with CDMS are making native MS workflow even more important. However, sample preparation remains a key challenge for many laboratories. Through innovative microfluidic technologies and automated online buffer exchange solutions, Andson Biotech is helping researchers reduce workflow complexity, preserve sample integrity, and focus more time on scientific discovery.
The Andson Biotech team looks forward to connecting with scientists, collaborators, and industry partners throughout the conference. Attendees are invited to learn more about Andson’s automated sample preparation solutions and explore emerging applications in native mass spectrometry, bioprocess monitoring, protein characterization, and advanced biotherapeutic development.
About Andson Biotech
Andson Biotech develops innovative microfluidic and automated sample preparation technologies that simplify mass spectrometry workflows. By automating online buffer exchange and related sample preparation steps, Andson enables researchers to improve efficiency, enhance reproducibility, and accelerate scientific discovery across biopharmaceutical development and life science research applications.
